A controlled clinical trial in advanced ovarian cancer
- PMID: 7039940
- DOI: 10.1016/s0009-9260(82)80049-4
A controlled clinical trial in advanced ovarian cancer
Abstract
Thirty-eight patients with an advanced ovarian cancer (FIGO stage III and IV) were randomly allocated to treatment, either with melphalan (M) or a combination of adriamycin, 5-fluorouracil and cyclophosphamide (CAF) to determine the effect on survival. Actuarial survival of the two treatment groups was the same but the combination was more toxic.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
